XML 35 R23.htm IDEA: XBRL DOCUMENT v3.22.2.2
Commitments
 9 Months Ended
Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS

16. COMMITMENTS

 

Lease Commitment

 

On November 20, 2017, Xi’an TCH entered into a lease for its office from December 1, 2017 through November 30, 2020. The monthly rent was RMB 36,536 ($5,600) with quarterly payment in advance. This lease expired in November 2020. The Company entered a new lease contract for the same location from January 1, 2021 through December 31, 2023 with monthly rent of RMB 36,536 ($5,600), to be paid every half year in advance.

The components of lease costs, lease term and discount rate with respect of the office lease with an initial term of more than 12 months are as follows:

 

   Nine Months
Ended		 
   September 30,
2022		 
Operating lease cost – amortization of ROU  $46,593 
Operating lease cost – interest expense on lease liability  $3,178 
Weighted Average Remaining Lease Term - Operating leases   1.25 years 
Weighted Average Discount Rate - Operating leases   5%

 

   Nine Months
Ended		 
   September 30,
2021		 
Operating lease cost– amortization of ROU  $45,299 
Operating lease cost – interest expense on lease liability  $5,513 

 

   Three Months
Ended
September 30,
2022		 
Operating lease cost – amortization of ROU  $15,194 
Operating lease cost – interest expense on lease liability  $765 

 

    Three Months
Ended
September 30,
2021		  
Operating lease cost – amortization of ROU   $ 15,329  
Operating lease cost – interest expense on lease liability   $ 1,610  

 

The following is a schedule, by years, of maturities of the office lease liabilities as of September 30, 2022:

 

For the year ended September 30, 2023,  $61,753 
Total undiscounted cash flows   61,753 
Less: imputed interest   (1,519)
Present value of lease liabilities  $60,234 

 

Employment Agreement

 

On May 8, 2020, the Company entered an employment agreement with Yongjiang Shi, the Company’s CFO for 24 months. The monthly salary was RMB 16,000 ($2,200). The Company will grant the CFO no less than 5,000 shares of the Company’s common stock annually; however, as of this report date, the Board of Directors and Compensation Committee have not approved the number of shares to be given to the CFO, nor any stock reward agreement has been signed.

On May 6, 2022, the Company entered another employment agreement with Mr. Shi for 24 months with monthly salary of RMB 18,000 ($2,500). The Company will grant the CFO no less than 5,000 shares of the Company’s common stock annually; however, as of this report date, the Board of Directors and Compensation Committee have not approved the number of shares to be given to the CFO, nor any stock reward agreement has been signed.  

Investment Banking Engagement Agreement

 

On October 10, 2019, the Company entered an investment banking agreement with an investment banking firm to engage it as the exclusive lead underwriter for a registered securities offering of up to $20 million. The Company shall pay the investment banker an equity retainer fee of 15,000 shares of the restricted Common Stock of the Company (10,000 shares was issued within 10 business days of signing the agreement, and remaining 5,000 shares will be paid upon completion of the offering). The agreement expired in March 2021.

 

On May 2, 2021, the Company entered an agreement with an investment banker (which will serve as the exclusive placement agent or exclusive lead underwriter of the Company) with the intension to raise approximately $10,000,000 from either a public offering or a private placement. Under the agreement, upon the closing of the financing, the Company will pay Univest Securities, LLC (the “Underwriter” or “Univest”) a discount equal to 8% of the gross proceeds raised in the offering, a non-accountable expense allowance equal to one percent (1%) of the gross proceeds of the offering, as well as underwriter warrants to purchase that number of shares of common stock and accompanying Warrants equal to 5% of the shares of common stock and Warrants sold in the offering, including upon exercise by the Underwriter of its over-allotment option (“Underwriter Warrants”). The Underwriter Warrants shall be exercisable at any time, and from time to time, in whole or in part, during the period commencing 180 days from the date of commencement of sales of the offering, which period shall not extend further than five years from the date of commencement of sales of the offering in compliance with FINRA Rule 5110(g)(8)(A). After an initial period of six months from the agreement entering date, this engagement may be terminated at any time by either party upon 10 days written notice to the other party, effective upon receipt of written notice to that effect by the other party. The Company filed an S-1 with the SEC on July 28, 2021.